1
/
of
1
Elabscience
SKU:PKSV030279
Recombinant 2019-nCoV NP CTD domain V2(C-6His)
Recombinant 2019-nCoV NP CTD domain V2(C-6His)
Regular price
$680.00 USD
Regular price
Sale price
$680.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant 2019-nCoV NP CTD domain V2(C-6His), a cutting-edge product designed to address the urgent need for effective solutions in combating the 2019 novel coronavirus (2019-nCoV). This meticulously engineered protein offers a highly reliable and versatile tool for researchers and scientists engaged in the study of this viral strain.
Crafted through advanced recombinant technology, the 2019-nCoV NP CTD domain V2(C-6His) exhibits exceptional purity and stability, ensuring accurate and reproducible results in various experimental settings. Its specific design targets the nucleocapsid (NP) protein's C-terminal domain (CTD), a crucial component of the 2019-nCoV viral structure.
With its C-terminal hexahistidine (C-6His) tag, this recombinant protein facilitates efficient purification and detection, streamlining laboratory workflows and enhancing experimental efficiency. Its high affinity for metal affinity chromatography enables rapid and reliable isolation, enabling researchers to focus on their investigations without compromising on quality or time.
The Recombinant 2019-nCoV NP CTD domain V2(C-6His) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Its exceptional purity and stability make it an ideal choice for a wide range of applications, including protein-protein interaction studies, structural biology, and vaccine development.
This product is supplied in a convenient lyophilized format, preserving its integrity and extending its shelf life. Upon reconstitution, it readily assumes its functional form, ready for immediate use in your research endeavors. Each vial contains a generous quantity of the recombinant protein, providing ample material for multiple experiments and reducing the need for frequent reordering.
In summary, the Recombinant 2019-nCoV NP CTD domain V2(C-6His) represents a breakthrough solution for researchers seeking a reliable and efficient tool to investigate the 2019-nCoV viral strain. Its exceptional purity, stability, and ease of use make it an indispensable asset in the fight against this global health threat. Trust in this cutting-edge product to advance your scientific endeavors and contribute to the collective effort in combating the 2019-nCoV pandemic.
Crafted through advanced recombinant technology, the 2019-nCoV NP CTD domain V2(C-6His) exhibits exceptional purity and stability, ensuring accurate and reproducible results in various experimental settings. Its specific design targets the nucleocapsid (NP) protein's C-terminal domain (CTD), a crucial component of the 2019-nCoV viral structure.
With its C-terminal hexahistidine (C-6His) tag, this recombinant protein facilitates efficient purification and detection, streamlining laboratory workflows and enhancing experimental efficiency. Its high affinity for metal affinity chromatography enables rapid and reliable isolation, enabling researchers to focus on their investigations without compromising on quality or time.
The Recombinant 2019-nCoV NP CTD domain V2(C-6His) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Its exceptional purity and stability make it an ideal choice for a wide range of applications, including protein-protein interaction studies, structural biology, and vaccine development.
This product is supplied in a convenient lyophilized format, preserving its integrity and extending its shelf life. Upon reconstitution, it readily assumes its functional form, ready for immediate use in your research endeavors. Each vial contains a generous quantity of the recombinant protein, providing ample material for multiple experiments and reducing the need for frequent reordering.
In summary, the Recombinant 2019-nCoV NP CTD domain V2(C-6His) represents a breakthrough solution for researchers seeking a reliable and efficient tool to investigate the 2019-nCoV viral strain. Its exceptional purity, stability, and ease of use make it an indispensable asset in the fight against this global health threat. Trust in this cutting-edge product to advance your scientific endeavors and contribute to the collective effort in combating the 2019-nCoV pandemic.
Share
